Logo-bi
Original Research
Hamid Soraya, Maryam Rameshrad, Aram Mokarizadeh, Alireza Garjani*
Bioimpacts. 2015;5(1): 3-8. doi: 10.15171/bi.2015.02
PMCID: PMC4401166     PMID: 25901291     Scopus ID: 84924853787    
Original Research
Hamed Hamishehkar, Soheila Hosseini, Abdolhossein Naseri, Azam Safarnejad, Farzaneh Rasoulzadeh*
Bioimpacts. 2016;6(3): 125-133. doi: 10.15171/bi.2016.19
PMCID: PMC5108985     PMID: 27853676     Scopus ID: 85003815216    
Original Article
Samira Gholizadeh ORCID, Hossein Haghaei, Hosna Karami, Somaieh Soltani* ORCID, Mostafa Zakariazadeh, Javad Shokri
Bioimpacts. 2023;13(2): 109-121. doi: 10.34172/bi.2022.23383
PMCID: PMC10182447     PMID: 37193080     Scopus ID: 85152094869    
Interaction of the Fingolimod with HSA was studied using multi-spectroscopic and molecular modeling methods. Fingolimod binds to the binding site II of HSA via hydrogen bonds and Van der Walls forces. The binding is enthalpy driven. Fingolimod interaction with HSA leads to the conformational change of HSA.
Review
Farkhonde Hasannejad ORCID, Leila Montazeri, João F Mano* ORCID, Shahin Bonakdar* ORCID, Ahmad ‎ Fazilat
Bioimpacts. 2024;14(3): 29945. doi: 10.34172/bi.2023.29945
PMCID: PMC11199935     PMID: 38938752     Scopus ID: 85194769935    
Review
Ali Rahmani ORCID, Rahim Jafari* ORCID, Samad Nadri* ORCID
Bioimpacts. 2025;15: 30160 | Published on: 2024 Aug 03. doi: 10.34172/bi.30160
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge